Entering text into the input field will update the search result below

Semler Scientific, Inc. (SMLR) CEO Douglas Murphy-Chutorian on Q1 2022 Results - Earnings Call Transcript

May 02, 2022 8:54 PM ETSemler Scientific, Inc. (SMLR)
SA Transcripts profile picture
SA Transcripts

Semler Scientific, Inc. (NASDAQ:SMLR) Q1 2022 Earnings Conference Call May 2, 2022 10:30 AM ET

Company Participants

Douglas Murphy-Chutorian - CEO

Dennis Rosenberg - Chief Marketing Officer

Andrew Weinstein - SVP, Finance and Accounting

Conference Call Participants

Brooks O’Neil - Lake Street Capital Markets LLC

Marc Wiesenberger - B. Riley Securities, Inc.


Good day, and welcome to the Semler Scientific First Quarter 2022 Financial Results Conference Call. All participants will be in listen-only mode. [Operator Instructions] After today’s presentation, there will be an opportunity to ask questions. [Operator Instructions] Please note this event is being recorded.

Before we begin, Semler Scientific would like to remind you that this conference call may contain forward-looking statements. Such statements can be identified by words such as may, will, expect, anticipate, intend, estimate, or words with similar meanings, and such statements involve a number of risks and uncertainties that could cause Semler Scientific’s actual results to differ materially from those discussed here. These risks include continued uncertainty due to the ongoing COVID-19 pandemic, and more recently the Russian invasion of Ukraine, risks associated with Semler Scientific’s extension of QuantaFlo additional cardiovascular diseases and it's distribution of Insulin Insights as well as other risks associated with Semler Scientific’s business.

Please note that these forward-looking statements reflect Semler Scientific’s opinion only as of the date of this presentation and it undertakes no obligation to revise or publicly release the results of any revision to these forward-looking statements in light of new information or future events. Please refer to Semler Scientific’s SEC filings for a more detailed description of the risk factors that may affect Semler Scientific’s results and these forward-looking statements.

Now, I would like to introduce Doug Murphy-Chutorian, CEO of Semler Scientific.

Douglas Murphy-Chutorian

Good afternoon, everyone and thank you for joining us for our

Recommended For You


To report an error in this transcript, .Contact us to add your company to our coverage or use transcripts in your business. Learn more about Seeking Alpha transcripts here. Your feedback matters to us!
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.